Boner hitting $90m while HIMS is a $6b company
Peptides the biggest bio hacking phenomenon in th...
Twitter
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights
The author compares the market capitalizations of Boner ($90m) and HIMS ($6b), noting that Eli Lilly (a $1T company) is paired with the biohacking phenomenon peptides. Based on these valuations and the comparison to HIMS, the author suggests that $PEPTIDES should reprice much higher in the coming days.
Ask about this postAnswers are grounded in this post's content.
Tweet
About John
John
By CryptoGodJohn
👑 For first access to all my trades, onchain plays, and daily market insights signup to @wealthgroup 🔥 My posts are not financial advice @rainbetcom